logo
Sign in

NVNOW Stock Price, Chart, Stats & News

enVVeno Medical Corporation
Save
73.65M
Market cap
Current P/E
Forward P/E

NVNOW chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
Operating margin
Pretax margin
Net margin
Effective tax rate
ROA
-65.87%
ROE
-60.88%
D/E
0.03x
Interest coverage ratio

NVNOW valuation

P/E
P/S
P/B
0.23x
P/CF
-0.40x
P/FCF
-0.01x
P/OCF
-0.40x
PEG
-0.01x
EV multiple
-0.13x

About

enVVeno Medical Corporation is a medical device firm dedicated to developing advanced bioprosthetic, tissue-based solutions with the aim of elevating the standard of care for various venous diseases. Central to its product pipeline is the VenoValve, a surgical implant currently under development specifically designed to address profound chronic venous insufficiency affecting the deep veins. When surgically positioned within the femoral vein, this innovative device functions as a unidirectional valve, thereby effectively restoring optimal blood flow in the leg.

Similar securities

Based on sector and market capitalization

Report issue